📈 GLP-1 winners are priced to perfection — take the other side of the spread trade
Chamath's read off the Morgan Stanley basket that went long the GLP-1 winners (Lilly, Novo Nordisk) and short the potentially disrupted healthcare names (Dexcom, DaVita) and returned ~80% in ten months: the market is pricing a panacea, the mechanism of action and long-term physiology are still unresolved, and no one wants to hear the bear case — so it is a bad point in the cycle to be a buyer and he would take the other side of the trade. The GLP-1 hype cycle is as overextended as the AI/NVIDIA one.
0
CONVICTION
peaked 35.2 EMBER
DORMANT
band · contested
▼ SHORT LLY
expression · bearish equities
MISS
outcome · R -58.1% · α -98.7%
2024-10-20
window closed
⚠ CONFLICTING IDEAS ON THE SAME TICKER
— the board is arguing with itself; net it before trading (ticker view →)
LLY ·
Retatrutide: Lilly's premium peptide upgrade path
LONG
EMBER 29.0
← stronger than this idea (10.6)
NVO ·
Retatrutide: Lilly's premium peptide upgrade path
LONG
EMBER 29.0
← stronger than this idea (10.6)
⚖ Why this verdict
fully deterministic — evaluate.py replays this from daily closes; nothing below is editable or hand-set
- Window: 2023-10-20 → 2024-10-20 — first mention + 12-month horizon, then the window locks.
- The call: ▼ SHORT LLY (primary play). LLY rose 58.1% over the window → direction-adjusted R = -58.1% (the call lost money).
- Benchmark: holding SPY over the same window returned +40.7%
→ α = -58.1 − (+40.7) = -98.7%
— what this call made or lost against just owning the index. This is the number the verdict uses.
Stock-selection read: -17.4% — did LLY move the predicted way relative to the market. The two only differ on a SHORT: this call was right about direction relative to the index but still cost money versus holding it.
- Rule fired:
· HIT — R ≥ +10% AND α ≥ +5· PARTIAL — R ≥ +5% OR α ≥ 0▶ MISS — everything else
- Credit: supporters of a MISS earn 0 each, opposers the inverse — this feeds the scoreboard weights. supported: Chamath | opposed: Friedberg, Jason
Conviction timeline
bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15
Plays vs SPY · % since first mention (2023-10-20)
Plays
| expression | symbol | kind | relevance | rationale |
|---|---|---|---|---|
| ▼ SHORT | LLY | stock | PRIMARY | named as a long leg of the overextended GLP-1 winners basket |
| ▼ SHORT | NVO | stock | adjacent | the other named winner; 5x'd in five years to ~$350B on the promise of the drug |
Mention log
Chamath
equities w=0.84 · n=160
· E150 (2023-10-20) · explicit_prediction · strength 3
▶ 1:17:51
SUPPORT
“From an economic market perspective, I think that these things are priced to perfection. It's kind of like NVIDIA ... It's a tough point in the cycle to be a buyer, I think, as an economic actor.”
Jason
equities w=0.97 · n=105
· E150 (2023-10-20) · sentiment · strength 2
▶ 1:19:56
OPPOSE
“But if you're making a trade, that seems like a hard trade to make. And just to give even some more color to it, Novo Nordisk announced that it was halting its ozempic kidney disease trial early because it was so conclusive.”
Friedberg
equities w=0.87 · n=120
· E150 (2023-10-20) · sentiment · strength 2
▶ 1:20:18
OPPOSE
“I mean, remember, over 40% of Americans are clinically obese. It's sorry, almost 60% now. It's an extraordinary health epidemic in the United States. And if this drug can have this sort of an effect, it can reduce costs across the health care system.”
RO
Robert F. Kennedy Jr.
(guest ×0.5)
no equities track record
· E194 (2024-08-30) · explicit_prediction · strength 2
▶ 1:48:32
SUPPORT
“But that company's entire value is based upon the projections of what is going to sell in the United States. And that company is pouring tens of millions of dollars into lobbying to pass this bill that will make Medicare pay for it for every American who is obese.”
Who built this conviction
each voice's total force on the score — supports and opposes from every mention, weighted exactly as the replay applied them · share = % of all mention-driven movement
⏳ decay drained -13.5 over the idea's life — that's time passing, attributed to no one
Score events
| episode | kind | Δ | after | note |
|---|---|---|---|---|
| E150 2023-10-20 | init | +35.2 | 35.2 | E150 born by Chamath (explicit_prediction x3) [w=0.84] |
| E150 2023-10-20 | oppose | -11.7 | 23.5 | E150 Jason opposes x2 [w=0.97] |
| E150 2023-10-20 | oppose | -10.4 | 13.1 | E150 Friedberg opposes x2 [w=0.87] |
| E151 2023-10-27 | decay | -0.5 | 12.6 | E151 silent |
| E152 2023-11-03 | decay | -0.5 | 12.1 | E152 silent |
| E156 2023-12-08 | decay | -0.5 | 11.6 | E156 silent |
| E157 2023-12-16 | decay | -0.5 | 11.1 | E157 silent |
| E158 2023-12-23 | decay | -0.4 | 10.7 | E158 silent |
| E159 2023-12-29 | decay | -0.4 | 10.3 | E159 silent |
| E160 2024-01-06 | decay | -0.4 | 9.9 | E160 silent |
| E161 2024-01-13 | decay | -0.4 | 9.5 | E161 silent |
| E162 2024-01-19 | decay | -0.4 | 9.1 | E162 silent |
| E163 2024-01-26 | decay | -0.4 | 8.7 | E163 silent |
| E164 2024-02-02 | decay | -0.3 | 8.4 | E164 silent |
| E165 2024-02-09 | decay | -0.3 | 8.0 | E165 silent |
| E166 2024-02-16 | decay | -0.3 | 7.7 | E166 silent |
| E167 2024-02-23 | decay | -0.3 | 7.4 | E167 silent |
| E168 2024-03-01 | decay | -0.3 | 7.1 | E168 silent |
| E169 2024-03-08 | decay | -0.3 | 6.8 | E169 silent |
| E170 2024-03-15 | decay | -0.3 | 6.6 | E170 silent |
| E171 2024-03-22 | decay | -0.3 | 6.3 | E171 silent |
| E172 2024-03-29 | decay | -0.3 | 6.0 | E172 silent |
| E173 2024-04-05 | decay | -0.2 | 5.8 | E173 silent |
| E174 2024-04-12 | decay | -0.2 | 5.6 | E174 silent |
| E175 2024-04-19 | decay | -0.2 | 5.3 | E175 silent |
| E176 2024-04-26 | decay | -0.2 | 5.1 | E176 silent |
| E177 2024-05-03 | decay | -0.2 | 4.9 | E177 silent |
| E178 2024-05-10 | decay | -0.2 | 4.7 | E178 silent |
| E179 2024-05-17 | decay | -0.2 | 4.5 | E179 silent |
| E180 2024-05-24 | decay | -0.2 | 4.4 | E180 silent |
| E181 2024-05-31 | decay | -0.2 | 4.2 | E181 silent |
| E182 2024-06-07 | decay | -0.2 | 4.0 | E182 silent |
| E183 2024-06-14 | decay | -0.2 | 3.9 | E183 silent |
| E184 2024-06-20 | decay | -0.2 | 3.7 | E184 silent |
| E185 2024-06-29 | decay | -0.1 | 3.6 | E185 silent |
| E186 2024-07-04 | decay | -0.1 | 3.4 | E186 silent |
| E187 2024-07-12 | decay | -0.1 | 3.3 | E187 silent |
| E188 2024-07-19 | decay | -0.1 | 3.1 | E188 silent |
| E189 2024-07-26 | decay | -0.1 | 3.0 | E189 silent |
| E190 2024-08-02 | decay | -0.1 | 2.9 | E190 silent |
| E191 2024-08-09 | decay | -0.1 | 2.8 | E191 silent |
| E192 2024-08-16 | decay | -0.1 | 2.7 | E192 silent |
| E193 2024-08-23 | decay | -0.1 | 2.6 | E193 silent |
| E194 2024-08-30 | reinforce | +11.0 | 13.5 | E194 Robert F. Kennedy Jr. support x2 (new voice) [w=0.50] |
| E195 2024-09-06 | decay | -0.5 | 13.0 | E195 silent |
| E196 2024-09-20 | decay | -0.5 | 12.5 | E196 silent |
| E197 2024-09-27 | decay | -0.5 | 12.0 | E197 silent |
| E198 2024-10-03 | decay | -0.5 | 11.5 | E198 silent |
| E199 2024-10-11 | decay | -0.5 | 11.0 | E199 silent |
| E200 2024-10-18 | decay | -0.4 | 10.6 | E200 silent |